Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19

References

• Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL et al, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3;579(7798):270–14. doi:10.1038/s41586-020-2012-7. PMID: 7095418.
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–33. doi:10.1056/NEJMoa2001017. PMID: 7092803.
   PubMed Web of Science ®Google Scholar
• Johns Hopkins University. The center for systems science and engineering (CSSE) COVID-19 dashboard 2021. Available from: https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6
   Google Scholar
• Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Musser BJ, Soo Y, Rofail D, Im J, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021 Jan 21;384(3):238–51. doi:10.1056/NEJMoa2035002. PMID: 7781102.
   PubMed Web of Science ®Google Scholar
• Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med. 2021 Jan 21;384(3):229–37. doi:10.1056/NEJMoa2029849. PMID: 7646625.
   PubMed Web of Science ®Google Scholar
• Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R. Naturally occurring antibodies devoid of light chains. Nature. 1993 Jun 3;363(6428):446–48. doi:10.1038/363446a0. PMID: 8502296.
   PubMed Web of Science ®Google Scholar
• Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82(1):775–97. doi:10.1146/annurev-biochem-063011-092449. PMID: 23495938.
   PubMed Web of Science ®Google Scholar
• Pardon E, Laeremans T, Triest S, Rasmussen SG, Wohlkonig A, Ruf A, Muyldermans S, Hol WG, Kobilka BK, Steyaert J. A general protocol for the generation of Nanobodies for structural biology. Nat Protoc. 2014 Mar;9(3):674–93. doi:10.1038/nprot.2014.039. PMID: 4297639.
   PubMed Web of Science ®Google Scholar
• Koenig PA, Das H, Liu H, Kummerer BM, Gohr FN, Jenster LM, Schiffelers LDJ, Tesfamariam YM, Uchima M, Wuerth JD, et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science. 2021 Feb 12;371(6530). doi:10.1126/science.abe6230. PMID: 7932109.
   Web of Science ®Google Scholar
• Xu J, Xu K, Jung S, Conte A, Lieberman J, Muecksch F, Lorenzi JCC, Park S, Schmidt F, Wang Z, et al. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 Jul;595(7866):278–82. doi:10.1038/s41586-021-03676-z. PMID: 8260353.
   PubMed Web of Science ®Google Scholar
• Esparza TJ, Martin NP, Anderson GP, Goldman ER, Brody DL. High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme. Sci Rep. 2020 Dec 22;10(1):22370. doi:10.1038/s41598-020-79036-0. PMID: 7755911.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Nambulli S, Xiao Z, Liu H, Sang Z, Duprex WP, Schneidman-Duhovny D, Zhang C, Shi Y. Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science. 2020 Dec 18;370(6523):1479–84. doi:10.1126/science.abe4747. PMID: 7857400.
   PubMed Web of Science ®Google Scholar
• Pymm P, Adair A, Chan LJ, Cooney JP, Mordant FL, Allison CC, Lopez E, Haycroft ER, O’Neill MT, Tan LL, et al. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 May 11;118(19):e2101918118. doi:10.1073/pnas.2101918118. PMID: 8126837.
   PubMed Web of Science ®Google Scholar
• Li T, Cai H, Yao H, Zhou B, Zhang N, van Vlissingen MF, Kuiken T, Han W, GeurtsvanKessel CH, Gong Y, et al. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun. 2021 Jul 30;12(1):4635. doi:10.1038/s41467-021-24905-z. PMID: 8324831.
   PubMed Web of Science ®Google Scholar
• Guttler T, Aksu M, Dickmanns A, Stegmann KM, Gregor K, Rees R, Taxer W, Rymarenko O, Schunemann J, Dienemann C, et al. Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. EMBO J. 2021 Oct 1;40(19):e107985. doi:10.15252/embj.2021107985. PMID: 8420576.
   PubMed Web of Science ®Google Scholar
• Schoof M, Faust B, Saunders RA, Sangwan S, Rezelj V, Hoppe N, Boone M, Billesbolle CB, Puchades C, Azumaya CM, et al. An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science. 2020 Dec 18;370(6523):1473–79. doi:10.1126/science.abe3255. PMID: 7857409.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271–280 e8. doi:10.1016/j.cell.2020.02.052. PMID: 7102627.
   PubMed Web of Science ®Google Scholar
• Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020 Apr;5(4):562–69. doi:10.1038/s41564-020-0688-y. PMID: 7095430.
   PubMed Web of Science ®Google Scholar
• Martin AC. Accessing the Kabat antibody sequence database by computer. Proteins. 1996 May;25(1):130–33. doi:10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.0.CO;2-L. PMID: 8727325.
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Dec 10;183(6):1735. doi:10.1016/j.cell.2020.11.032.
   PubMed Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar 13;367(6483):1260–63. doi:10.1126/science.abb2507.
   PubMed Web of Science ®Google Scholar
• Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang D, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, et al. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021 Feb 19;371(6531):823–29. doi:10.1126/science.abf4830. PMID: 7963221.
   PubMed Web of Science ®Google Scholar
• Yao H, Cai H, Li T, Zhou B, Qin W, Lavillette D, Li D. A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2. PLoS Pathog. 2021 Mar;17(3):e1009328. doi:10.1371/journal.ppat.1009328. PMID: 7959386.
   PubMed Web of Science ®Google Scholar
• Barnes CO, Jette CA, Abernathy ME, Dam KA, Esswein SR, Gristick HB, Malyutin AG, Sharaf NG, Huey-Tubman KE, Lee YE, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020 Dec;588(7839):682–87. doi:10.1038/s41586-020-2852-1. PMID: 8092461.
   PubMed Web of Science ®Google Scholar
• Webb NE, Montefiori DC, Lee B. Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies. Nat Commun. 2015 Sep 29;6(1):8443. doi:10.1038/ncomms9443.
   PubMed Web of Science ®Google Scholar
• Van Heeke G, Allosery K, De Brabandere V, De Smedt T, Detalle L, de Fougerolles A. Nanobodies(R) as inhaled biotherapeutics for lung diseases. Pharmacol Ther. 2017 Jan;169:47–56. doi:10.1016/j.pharmthera.2016.06.012. PMID: 27373507.
   PubMed Web of Science ®Google Scholar
• Larios Mora A, Detalle L, Gallup JM, Van Geelen A, Stohr T, Duprez L, Ackermann MR. Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs. MAbs. 2018 Jul;10(5):778–95. doi:10.1080/19420862.2018.1470727. PMID: 6150622.
   PubMed Web of Science ®Google Scholar
• Detalle L, Stohr T, Palomo C, Piedra PA, Gilbert BE, Mas V, Millar A, Power UF, Stortelers C, Allosery K, et al. Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection. Antimicrob Agents Chemother. 2016 Jan;60(1):6–13. doi:10.1128/AAC.01802-15. PMID: 4704182.
   PubMed Web of Science ®Google Scholar
• Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587–95. doi:10.1073/pnas.2009799117. PMID: 7368255.
   PubMed Web of Science ®Google Scholar
• Huo J, Mikolajek H, Le Bas A, Clark JJ, Sharma P, Kipar A, Dormon J, Norman C, Weckener M, Clare DK, et al. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun. 2021 Sep 22;12(1):5469. doi:10.1038/s41467-021-25480-z. PMID: 8458290.
   PubMed Web of Science ®Google Scholar
• Li W, Schafer A, Kulkarni SS, Liu X, Martinez DR, Chen C, Sun Z, Leist SR, Drelich A, Zhang L, et al. High potency of a bivalent human VH domain in SARS-CoV-2 animal models. Cell. 2020 Oct 15;183(2):429–441 e16. doi:10.1016/j.cell.2020.09.007. PMID: 7473018.
   PubMed Web of Science ®Google Scholar
• Ye G, Gallant J, Zheng J, Massey C, Shi K, Tai W, Odle A, Vickers M, Shang J, Wan Y, et al. The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. Elife. 2021 Aug 2;10. doi:10.7554/eLife.64815. PMID: 8354634.
   Web of Science ®Google Scholar
• Nambulli S, Xiang Y, Tilston-Lunel NL, Rennick LJ, Sang Z, Klimstra WB, Reed DS, Crossland NA, Shi Y, Duprex WP. Inhalable nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Sci Adv. 2021 May;7(22). doi:10.1126/sciadv.abh0319. PMID: 8153718.
   PubMed Web of Science ®Google Scholar
• Moliner-Morro A, JS D, Karl V, Perez Vidakovics L, Murrell B, McInerney GM, Hanke L. Picomolar SARS-CoV-2 neutralization using multi-arm PEG nanobody constructs. Biomolecules. 2020 Dec 11;10(12):1661. doi:10.3390/biom10121661. PMID: 7764822.
   PubMed Web of Science ®Google Scholar
• Miller A, Carr S, Rabbitts T, Ali H. Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats. MAbs. 2020 Jan-Dec;12(1):1752529. doi:10.1080/19420862.2020.1752529. PMID: 7188389.
   PubMed Web of Science ®Google Scholar
• Zupancic JM, Desai AA, Schardt JS, Pornnoppadol G, Makowski EK, Smith MD, Kennedy AA, Garcia de Mattos Barbosa M, Cascalho M, Lanigan TM, et al. Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis. Cell Chem Biol. 2021 Sep 16;28(9):1379–1388 e7. doi:10.1016/j.chembiol.2021.05.019. PMID: 8223476.
   PubMed Web of Science ®Google Scholar
• Huo J, Le Bas A, Ruza RR, Duyvesteyn HME, Mikolajek H, Malinauskas T, Tan TK, Rijal P, Dumoux M, Ward PN, et al. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2020 Sep;27(9):846–54. doi:10.1038/s41594-020-0469-6. PMID: 32661423.
   PubMed Web of Science ®Google Scholar
• Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data reduction and structure solution–from diffraction images to an initial model in minutes. Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859–66. doi:10.1107/S0907444906019949. PMID: 16855301.
   PubMedGoogle Scholar
• Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235–42. doi:10.1107/S0907444910045749. PMID: 3069738.
   PubMedGoogle Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126–32. doi:10.1107/S0907444904019158. PMID: 15572765.
   PubMedGoogle Scholar
• Liebschner D, Afonine PV, Baker ML, Bunkoczi G, Chen VB, Croll TI, Hintze B, Hung LW, Jain S, McCoy AJ, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861–77. doi:10.1107/S2059798319011471. PMID: 6778852.
   PubMedGoogle Scholar
• Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12–21. doi:10.1107/S0907444909042073. PMID: 2803126.
   PubMed Web of Science ®Google Scholar
• Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007 Sep 21;372(3):774–97. doi:10.1016/j.jmb.2007.05.022. PMID: 17681537.
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol. 1999;112:531–52. doi:10.1385/1-59259-584-7:531. PMID: 10027275.
   PubMedGoogle Scholar
• Chen SH, Haam J, Walker M, Scappini E, Naughton J, Martin NP. Production of Viral Constructs for Neuroanatomy, Calcium Imaging, and Optogenetics. Curr Protoc Neurosci. 2019 Apr;87(1):e66. doi:10.1002/cpns.66. PMID: 6530799.
   PubMedGoogle Scholar
• Bosco-Lauth AM, Hartwig AE, Porter SM, Gordy PW, Nehring M, Byas AD, VandeWoude S, Ragan IK, Maison RM, Bowen RA. Experimental infection of domestic dogs and cats with SARS-CoV-2: pathogenesis, transmission, and response to reexposure in cats. Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382–88. doi:10.1073/pnas.2013102117. PMID: 7585007.
   PubMed Web of Science ®Google Scholar
• Jia Q, Bielefeldt-Ohmann H, Maison RM, Maslesa-Galic S, Cooper SK, Bowen RA, Horwitz MA. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters. NPJ Vaccines. 2021 Mar 30;6(1):47. doi:10.1038/s41541-021-00321-8. PMID: 8009914.
   PubMed Web of Science ®Google Scholar